Literature DB >> 12631311

Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea.

Charles S Mgone1, Joyce M Mgone, Toshiaki Takasu, Kenji Miki, Ryuta Kawanishi, Peter G Asuo, Jacinta Kono, Katsuhiro Komase, Michael P Alpers.   

Abstract

Eighty-three children presented at Goroka Base Hospital in the Eastern Highlands Province (EHP) of Papua New Guinea over a period of 3 years and 9 months between February 1997 and November 2000 were confirmed to have subacute sclerosing panencephalitis (SSPE). Confirmation of the diagnosis was based on the demonstration of high titres of measles antibodies in the cerebrospinal fluid and/or serum in association with clinical features supportive of SSPE, including characteristic electroencephalographic changes and amplification of measles virus genome by reverse transcriptase polymerase chain reaction in some cases. The mean cerebrospinal fluid and serum enzyme immunoassay antibody levels among the SSPE patients were 38 250 and 860 580, respectively. The mean age of onset of SSPE was 7.9 +/- 2.6 years and ranged between 2 and 14 years. The overall male to female ratio was 1.2:1 and 1.4:1 for EHP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631311     DOI: 10.1046/j.1365-3156.2003.01020.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  1 in total

1.  Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Authors:  Laurens Manning; Moses Laman; Henry Edoni; Ivo Mueller; Harin A Karunajeewa; David Smith; Ilomo Hwaiwhanje; Peter M Siba; Timothy M E Davis
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.